Patents by Inventor Yung Hua Li

Yung Hua Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240098833
    Abstract: A method for mobility enhancement in wireless communication systems is provided. The method is performed by a User Equipment (UE) configured with a first Small Data Transmission (SDT) configuration by a first cell. The method includes receiving a Radio Resource Control (RRC) release message including a suspend configuration from the first cell; transitioning to an RRC INACTIVE state in response to receiving the RRC release message; receiving, in the RRC INACTIVE state, a System Information Block Type 1 (SIB1) including a second SDT configuration from a second cell; camping on the second cell in response to receiving the SIB1 from the second cell; and while the UE is camping on the second cell, refraining from using the first SDT configuration to initiate an SDT procedure associated with the second cell in a case that the UE does not support performing the SDT procedure associated with the second cell.
    Type: Application
    Filed: September 14, 2023
    Publication date: March 21, 2024
    Inventors: YUNG-LAN TSENG, YEN-HUA LI, HAI-HAN WANG, HUNG-CHEN CHEN
  • Patent number: 6923962
    Abstract: The invention relates to a compound that competitively inhibits binding of CSP to S. mutans histidine kinase. The compound is preferably a peptide or an antibody. The compound is preferably a derivative of [SEQ ID NO:2], a fragment of [SEQ ID NO:2] or a derivative of a fragment of [SEQ ID NO:2].
    Type: Grant
    Filed: April 10, 2001
    Date of Patent: August 2, 2005
    Inventors: Dennis Cvitkovitch, Peter C. Y. Lau, Yung Hua Li
  • Publication number: 20020081302
    Abstract: The invention relates to a compound that competitively inhibits binding of CSP to S. mutans histidine kinase. The compound is preferably a peptide or an antibody. The compound is preferably a derivative of [SEQ ID NO:2], a fragment of [SEQ ID NO:2] or a derivative of a fragment of [SEQ ID NO:2].
    Type: Application
    Filed: September 17, 2001
    Publication date: June 27, 2002
    Inventors: Dennis Cvitkovitch, Peter C.Y. Lau, Yung Hua Li